Why 80% of Clinical Trials Fail at Patient Enrollment—And How Medidata eCOA and Dot AI are Revolutionizing the $100B Market
For biopharma sponsors and Clinical Research Organizations (CROs) globally, the path from protocol design to First Patient In (FPI) has always been a treacherous bottleneck. Recent industry data reveals a staggering reality: 80% of all clinical trials face significant delays or mid-study halts due to patient recruitment and compliance issues. To solve these systemic bottlenecks, … Read more